100EGP
- Active ingredient
- lamivudine+zidovudine
- Form
- tablet
- Manufacturer
- eva pharma
- Route
- oral.solid
Uses
Used in combination with other antiretroviral medicines for the treatment of HIV-1 infection.
Do not use if
Contraindicated in patients with hypersensitivity to lamivudine, zidovudine, or formulation components.
Side effects
May cause anemia, neutropenia, nausea, headache, myopathy, or fatigue. Serious reactions include lactic acidosis and liver toxicity.
Warnings
Monitor for hematologic toxicity, myopathy, lactic acidosis, and hepatic complications. Medical supervision is essential.
How it works
Combination of two nucleoside reverse transcriptase inhibitors that suppress HIV replication.
Storage
Store at controlled room temperature in the original container.